China Pharma Holdings, Inc. (CPHI): Price and Financial Metrics
CPHI Price/Volume Stats
| Current price | $0.15 | 52-week high | $2.46 |
| Prev. close | $0.14 | 52-week low | $0.11 |
| Day low | $0.14 | Volume | 75,991 |
| Day high | $0.15 | Avg. volume | 546,421 |
| 50-day MA | $0.21 | Dividend yield | N/A |
| 200-day MA | $0.50 | Market Cap | 1.68M |
CPHI Stock Price Chart Interactive Chart >
CPHI Stock Summary
- CHINA PHARMA HOLDINGS INC's market capitalization of $1,589,159 is ahead of merely 0.36% of US-listed equities.
- With a price/sales ratio of 0.2, CHINA PHARMA HOLDINGS INC has a higher such ratio than merely 6.47% of stocks in our set.
- The volatility of CHINA PHARMA HOLDINGS INC's share price is greater than that of 94.14% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to CPHI, based on their financial statements, market capitalization, and price volatility, are SLQT, NAOV, BOXL, ALPP, and OPAD.
- CPHI's SEC filings can be seen here. And to visit CHINA PHARMA HOLDINGS INC's official web site, go to www.chinapharmaholdings.com.
CPHI Valuation Summary
- In comparison to the median Healthcare stock, CPHI's price/sales ratio is 95% lower, now standing at 0.2.
- Over the past 243 months, CPHI's EV/EBIT ratio has gone up 84.3.
Below are key valuation metrics over time for CPHI.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| CPHI | 2023-09-22 | 0.2 | 0.4 | -0.5 | -3.1 |
| CPHI | 2023-09-21 | 0.2 | 0.4 | -0.5 | -3.1 |
| CPHI | 2023-09-20 | 0.2 | 0.4 | -0.5 | -3.2 |
| CPHI | 2023-09-19 | 0.2 | 0.4 | -0.5 | -3.1 |
| CPHI | 2023-09-18 | 0.2 | 0.4 | -0.5 | -3.1 |
| CPHI | 2023-09-15 | 0.2 | 0.4 | -0.5 | -3.2 |
CPHI Growth Metrics
- Its 5 year cash and equivalents growth rate is now at -88.76%.
- The 3 year cash and equivalents growth rate now stands at 91.69%.
- Its 5 year revenue growth rate is now at -35.86%.
The table below shows CPHI's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 8.07246 | -1.192251 | -3.689376 |
| 2022-06-30 | 8.085156 | -1.86222 | -3.725272 |
| 2022-03-31 | 8.887559 | -0.852361 | -3.661639 |
| 2021-12-31 | 9.641925 | -0.249838 | -3.399476 |
| 2021-09-30 | 9.683661 | 0.283142 | -3.627794 |
| 2021-06-30 | 10.1057 | 0.5096 | -3.811021 |
CPHI's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CPHI has a Quality Grade of C, ranking ahead of 56.06% of graded US stocks.
- CPHI's asset turnover comes in at 0.493 -- ranking 88th of 677 Pharmaceutical Products stocks.
- DRNA, ONVO, and CASI are the stocks whose asset turnover ratios are most correlated with CPHI.
The table below shows CPHI's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.493 | 0.094 | -0.236 |
| 2021-03-31 | 0.538 | 0.177 | -0.174 |
| 2020-12-31 | 0.495 | 0.180 | -0.168 |
| 2020-09-30 | 0.494 | 0.153 | -1.332 |
| 2020-06-30 | 0.407 | 0.183 | -0.990 |
| 2020-03-31 | 0.306 | 0.105 | -0.802 |
Latest CPHI News From Around the Web
Below are the latest news stories about CHINA PHARMA HOLDINGS INC that investors may wish to consider to help them evaluate CPHI as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayPre-market stock movers are a hot topic this morning and we're checking on the biggest ones investors will want to watch on Friday! |
Is China Pharma Holding (CPHI) A Hidden Gem or A Value Trap?Unraveling the Financial Health of China Pharma Holding |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start the week off right with a look at the biggest pre-market stock movers worth watching on Monday morning! |
China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic DrugsChina Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its wholly-owned subsidiary Hainan Helpson Medical & Biotechnology Co., Ltd. (hereinafter referred to as "Helpson") has received the "Drug Supplementary Application Approval Notice" for its candesartan tablets by National Medical Products Administration of China (hereinafter referred to as NMPA"), indicating that the Company's candesartan tablets hav |
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock SplitChina Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-for-10 reverse stock split on its common stock effective Monday, March 6, 2023, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the common stock will continue on the NYSE American under the symbol "CPHI". The new CUSIP number for the common stock following the reverse stock split is 16941T-203. |
CPHI Price Returns
| 1-mo | N/A |
| 3-mo | -56.33% |
| 6-mo | N/A |
| 1-year | -89.74% |
| 3-year | -95.99% |
| 5-year | -93.33% |
| YTD | -84.36% |
| 2022 | -80.13% |
| 2021 | 8.25% |
| 2020 | 88.26% |
| 2019 | -7.86% |
| 2018 | 42.78% |
Continue Researching CPHI
Want to do more research on China Pharma Holdings Inc's stock and its price? Try the links below:China Pharma Holdings Inc (CPHI) Stock Price | Nasdaq
China Pharma Holdings Inc (CPHI) Stock Quote, History and News - Yahoo Finance
China Pharma Holdings Inc (CPHI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...